Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Recruiting 12Completed 4Unknown 3Terminated 3Active not recruiting 3Not yet recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Leukemia, Myeloid, Acute 12Myelodysplastic Syndromes 4Neoplasm Metastasis 3Melanoma 3Leukemia, Myelomonocytic, Chronic 3Breast Neoplasms 3Advanced Solid Tumor 3Recurrence 2Ovarian Neoplasms 2Lymphoma, B-Cell 2Leukemia, Monocytic, Acute 2Fallopian Tube Neoplasms 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Papillomavirus Infections 1Non-Squamous Non-small Cell Lung Cancer 1Neoplasms 1Nasopharyngeal Carcinoma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Microsatellite Instability 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Acute 1Leukemia, Basophilic, Acute 1Leukemia 1

Interventions

pembrolizumab 4Injections 3tislelizumab 2Nivolumab 2toripalimab 1atezolizumab 1Pemetrexed 1Paclitaxel 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Advanced Solid Tumor × Injections × Clear all
NCT05438329 2026-05-12

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

DualityBio Inc.

Phase 1/2 Active not recruiting
1,123 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06927687 2026-04-29

Study of ZG005 in Patients With Advanced Solid Tumors

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Phase 2 Active not recruiting
50 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06057922 2026-03-12

A Study YL201 in Patients With Selected Advanced Solid Tumors

MediLink Therapeutics (Suzhou) Co., Ltd.

Phase 1/2 Active not recruiting
990 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡